dr mike israetel tirzepatide Ozempic bodybuilders push for open access to weight loss drug Debating EVERYTHING With Dr. Mike

November 2025: FDA approved expanded Zepbound (tirzepatide) indication for moderate-to-severe obstructive sleep apnea in adults with obesity, following SURMOUNT-OSA trial data showing 62.8% reduction in apnea-hypopnea index the first drug approval for sleep apnea treatment

[1] [3] The combination may lead to more frequent or severe diarrhea with associated dehydration risk

Here are photos of his improvements: Conclusion and Summary I liked this case report

Shed provides access to Wegovy through a fully online, provider-led care model

104 weeks median Headline result 38% reduction in CV death or worsening heart failure (HR 0.62)

I've safely dropped to 257 pounds, and I even canceled my bariatric surgery